Artículo

Lavaggi, M.L.; Cabrera, M.; Aravena, M.d.l.A.; Olea-Azar, C.; López de Ceráin, A.; Monge, A.; Pachón, G.; Cascante, M.; Bruno, A.M.; Pietrasanta, L.I.; González, M.; Cerecetto, H. "Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation" (2010) Bioorganic and Medicinal Chemistry. 18(12):4433-4440
La versión final de este artículo es de uso interno. El editor solo permite incluir en el repositorio el artículo en su versión post-print. Por favor, si usted la posee enviela a
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

Phenazine 5,10-dioxides are prodrugs for antitumor therapy that undergo hypoxic-selective bioreduction to form cytotoxic species. Here we investigate the expanded system benzo[a]phenazine 7,12-dioxides as selective hypoxic cytotoxin-scaffold. The clonogenic survival of V79 cells on aerobic and anaerobic conditions, conduct us to study antiproliferative activity on Caco-2 tumoral cells in normoxia. Electrochemical, DNA-interaction and DNA-damage studies were performed to establish the mode of action. The results demonstrated the potential biological properties of the studied scaffold being derivatives 6-10 structural hits for further chemical-modifications to become into therapeutics for solid tumors. Compounds 6 and 8 with cytotoxicity against V79 cells in both conditions (aerobia and anaerobia) were also cytotoxic against Caco-2 tumoral cells in aerobiosis. © 2010 Elsevier Ltd. All rights reserved.

Registro:

Documento: Artículo
Título:Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation
Autor:Lavaggi, M.L.; Cabrera, M.; Aravena, M.d.l.A.; Olea-Azar, C.; López de Ceráin, A.; Monge, A.; Pachón, G.; Cascante, M.; Bruno, A.M.; Pietrasanta, L.I.; González, M.; Cerecetto, H.
Filiación:Laboratorio de Química Orgánica, Facultad de Ciencias-Facultad de Química, Universidad de la República, 11400 Montevideo, Uruguay
Departamento de Química Inorgánica y Analítica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Chile
Centro de Investigación en Farmacobiología Aplicada, Universidad de Navarra, Pamplona, Spain
Department of Biochemistry and Molecular Biology, Faculty of Biology, Institute of Biomedicine of University of Barcelona (IBUB), Barcelona, Spain
Departamento de Química Orgánica, Facultad de Farmacia y Bioquímica, Argentina
Centro de Microscopías Avanzadas, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina
Palabras clave:Benzo[a]phenazine 7,12-dioxides; Bioreductive agents; DNA fragmentation; benzo[a]phenazine 7,12 dioxide; cytotoxin; unclassified drug; antineoplastic agent; phenazine derivative; aerobic metabolism; animal cell; antineoplastic activity; article; cancer cell; cell proliferation; cell survival; clonogenesis; colon adenocarcinoma; controlled study; cytotoxicity; DNA damage; DNA fragmentation; drug DNA interaction; nonhuman; animal; CACO 2 cell line; cell hypoxia; cell line; chemistry; Colonic Neoplasms; DNA fragmentation; drug effects; hamster; human; synthesis; toxicity; Animals; Antineoplastic Agents; Caco-2 Cells; Cell Hypoxia; Cell Line; Colonic Neoplasms; Cricetinae; DNA Damage; DNA Fragmentation; Humans; Phenazines; Animals; Antineoplastic Agents; Caco-2 Cells; Cell Hypoxia; Cell Line; Colonic Neoplasms; Cricetinae; DNA Damage; DNA Fragmentation; Humans; Phenazines
Año:2010
Volumen:18
Número:12
Página de inicio:4433
Página de fin:4440
DOI: http://dx.doi.org/10.1016/j.bmc.2010.04.074
Título revista:Bioorganic and Medicinal Chemistry
Título revista abreviado:Bioorg. Med. Chem.
ISSN:09680896
CODEN:BMECE
CAS:Antineoplastic Agents; Phenazines; Antineoplastic Agents; Phenazines
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09680896_v18_n12_p4433_Lavaggi

Referencias:

  • Cater, D.B., Silver, I.A., (1960) Acta Radiol., 23, p. 233
  • Rockwell, S., Moulder, J.E., (1990) Int. J. Radiat. Oncol. Biol. Phys., 19, p. 197
  • Denny, W.A., (2001) Eur. J. Med. Chem., 36, p. 577
  • Yasuda, H., (2008) Nitric Oxide, 19, p. 205
  • Ruan, K., Song, G., Ouyang, G., (2009) J. Cell Biochem., 107, p. 1053
  • Brown, J.M., Wilson, W.R., (2004) Nat. Rev. Cancer, 4, p. 437
  • Lin, A.J., Cosby, L.A., Shansky, C.W., Sartorelli, A.C., (1972) J. Med. Chem., 15, p. 1247
  • Naylor, M.A., Thomson, P., (2001) Mini Rev. Med. Chem., 1, p. 17
  • Wardman, P., (2001) Curr. Med. Chem., 8, p. 739
  • Anderson, R.F., Shinde, S.S., Hay, M.P., Gamage, S.A., Denny, W.A., (2005) Org. Biomol. Chem., 3, p. 2167
  • Zhang, Z., Tanabe, K., Hatta, H., Nishimoto, S., (2005) Org. Biomol. Chem., 3, p. 1905
  • Jameson, M.B., Rischin, D., Pegram, M., Gutheil, J., Patterson, A.V., Denny, W.A., Wilson, W.R., (2009) Cancer Chemother. Pharmacol., p. 65. , 10.1007/s00280-009-1188-1
  • Cerecetto, H., González, M., (2001) Mini-Rev. Med. Chem., 1, p. 219
  • Cerecetto, H., González, M., Lavaggi, M.L., (2006) Med. Chem., 2, p. 315
  • Cerecetto, H., González, M., Lavaggi, M.L., Azqueta, A., Ezpeleta, O., López de Ceraín, A., Monge-Vega, A., (2005) J. Med. Chem., 48, p. 21
  • Cerecetto, H., González, M., Lavaggi, M.L., Porcal, W., (2005) J. Braz. Chem. Soc., 6, pp. 1290-1296
  • Cerecetto, H., González, M., Lavaggi, M.L., Aravena, M.A., Rigol, C., Olea-Azar, C., Azqueta, A., Bruno, A.M., (2006) Med. Chem., 2, p. 511
  • Pachón, O.G., Azqueta, A., Lavaggi, M.L., López de Ceraín, A., Creppy, E., Collins, A., Cerecetto, H., Cascante, M., (2008) Chem. Res. Toxicol., 21, p. 1578
  • Lavaggi, M.L., Cabrera, M., González, M., Cerecetto, H., (2008) Chem. Res. Toxicol., 21, p. 1900
  • Abu El-Haj, M., Dominy, B., Johnston, J., (1972) J. Org. Chem., 37, p. 589
  • Monge, A., Palop, J.A., López de Ceráin, A., Senador, V., Martínez-Crespo, F.J., Sáinz, Y., Narro, S., Greenhow, D.T., (1995) J. Med. Chem., 38, pp. 1786-1792
  • Urquiola, C., Vieites, M., Torre, M.H., Cabrera, M., Lavaggi, M.L., Cerecetto, H., González, M., Gambino, D., (2009) Bioorg. Med. Chem., 17, p. 1623
  • Aguirre, J.D., Angeles-Boza, A.M., Chouai, A., Pellois, J.P., Turro, C., Dunbar, K.R., (2009) J. Am. Chem. Soc., 131, p. 11353
  • Wang, J., Yang, X., (2009) Spectrochim. Acta A Mol. Biomol. Spectrosc., 74, p. 421
  • Biver, T., De Biasi, A., Secco, F., Venturini, M., Yarmoluk, S., (2005) Biophys. J., 89, p. 374
  • Pietrasanta, L.I., Smith, B.L., MacLeod, M.C., (2000) Chem. Res. Toxicol., 13, p. 351
  • Onoa, G.B., Cervantes, G., Moreno, V., Prieto, M.J., (1998) Nucleic Acids Res., 26, p. 1473
  • Mounir, M., Lorenzo, J., Ferrer, M., Prieto, M.J., Rossell, O., Avile's, F.X., Moreno, V., (2007) J. Inorg. Biochem., 101, p. 660
  • Lozano, C., Torres, J.L., Julia, L., Jimenez, A., Centelles, J.J., Cascante, M., (2005) FEBS Lett., 579, p. 4219
  • Zeman, E.M., Baker, M.A., Lemmon, M.J., Pearson, C.I., Adams, J.A., Brown, J.M., Lee, W.W., Tracy, M., (1989) Int. J. Radiat. Oncol. Biol. Phys., 16, p. 977
  • Cerecetto, H., Di Maio, R., González, M., Risso, M., Saenz, P., Seoane, G., Denicola, A., Olea-Azar, C., (1999) J. Med. Chem., 42, p. 1941
  • Mossman, B.T., (1983) Environ. Health Perspect., 53, p. 151
  • Fernández, L.A., Santo, M.R., Reta, M., Giacomelli, L., Cattana, R., Silber, J.J., Risso, M., Olea-Azar, C., (2005) Molecules, 10, p. 1197
  • Rodríguez, J., Gerpe, A., Aguirre, G., Kemmerling, U., Piro, O.E., Arán, V.J., Maya, J.D., Cerecetto, H., (2009) Eur. J. Med. Chem., 44, p. 1545

Citas:

---------- APA ----------
Lavaggi, M.L., Cabrera, M., Aravena, M.d.l.A., Olea-Azar, C., López de Ceráin, A., Monge, A., Pachón, G.,..., Cerecetto, H. (2010) . Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation. Bioorganic and Medicinal Chemistry, 18(12), 4433-4440.
http://dx.doi.org/10.1016/j.bmc.2010.04.074
---------- CHICAGO ----------
Lavaggi, M.L., Cabrera, M., Aravena, M.d.l.A., Olea-Azar, C., López de Ceráin, A., Monge, A., et al. "Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation" . Bioorganic and Medicinal Chemistry 18, no. 12 (2010) : 4433-4440.
http://dx.doi.org/10.1016/j.bmc.2010.04.074
---------- MLA ----------
Lavaggi, M.L., Cabrera, M., Aravena, M.d.l.A., Olea-Azar, C., López de Ceráin, A., Monge, A., et al. "Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation" . Bioorganic and Medicinal Chemistry, vol. 18, no. 12, 2010, pp. 4433-4440.
http://dx.doi.org/10.1016/j.bmc.2010.04.074
---------- VANCOUVER ----------
Lavaggi, M.L., Cabrera, M., Aravena, M.d.l.A., Olea-Azar, C., López de Ceráin, A., Monge, A., et al. Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation. Bioorg. Med. Chem. 2010;18(12):4433-4440.
http://dx.doi.org/10.1016/j.bmc.2010.04.074